HISTORY
Cascure Therapeutics: building a new future for cancer treatment technology.
2023 ~ now
2022 ~ 2020
2023 ~ now
2026
- 03 Shareholders’ meeting
- 01 Signed a Joint R&D Memorandum of Understanding (MOU) with Medici Bio Co., Ltd.
2025
-
10 Selected for the 2nd Post-TIPS Program and Signed the Agreement
(Project Period: Oct 1, 2025 ~ Mar 31, 2027) - 03 Shareholders’ meeting
- 01 Investment from Stonebridge ventures
2024
- 11 Investment from KIBO
- 03 Shareholders’ meeting
2023
- 10 Investment from Individual Investment Association
- 04 Appointed Jongmoon Kim as CEO
- 03 Shareholders’ meeting
2022 ~ 2020
2022
- 03 Shareholders’ meeting
- 02 CINDELA research published in PNAS
- 01 CRISPR Medicine New Companies to Follow 2023
2021
- 12TIPS Biz
- 01Shareholders’ meeting
2020
- 12Certification as a company R&D Center
- 10Certification as a venture business
- 09 Investment from Dayli Partners, Stonebridge Ventures
- 06 Establishment of Cascure therapeutics